Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Concord Biotech Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22
Months12121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARAR
FaceValue1.001.001.0010.00
     
Net Profit/Loss Before Extraordinary Items And Tax494.55412.57322.01237.52
     
Net CashFlow From Operating Activities244.52265.47246.00207.47
Net Cash Used In Investing Activities-159.99-154.61-157.95-111.79
Net Cash Used From Financing Activities-98.77-99.21-85.22-100.16
     
Net Inc/Dec In Cash And Cash Equivalents-14.2411.642.83-4.48
Cash And Cash Equivalents Begin of Year15.143.500.675.14
Cash And Cash Equivalents End Of Year0.9015.143.500.67
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
Net Profit/Loss Before Extraordinary Items And Tax494.55
Net CashFlow From Operating Activities244.52
Net Cash Used In Investing Activities-159.99
Net Cash Used From Financing Activities-98.77
Net Inc/Dec In Cash And Cash Equivalents-14.24
Cash And Cash Equivalents Begin of Year15.14
Cash And Cash Equivalents End Of Year0.90